New Key Statistics Module, Z-Score and F-Score
LIM:MRNA Key Ratios
Market Cap $ M | 31,689.61 |
Enterprise Value $ M | 24,470.61 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.66 |
Price/Sales | 6.20 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4,988.00 |
EPS (TTM) $ | -15.38 |
Beneish M-Score | -3.56 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -468.30 |
EV-to-EBIT | -5.69 |
EV-to-EBITDA | -6.48 |
PEG | -- |
Shares Outstanding M | 384.40 |
Net Margin (%) | -117.62 |
Operating Margin % | -92.92 |
Pre-tax Margin (%) | -86.85 |
Quick Ratio | 3.92 |
Current Ratio | 4.09 |
ROA % (ttm) | -31.83 |
ROE % (ttm) | -42.65 |
ROIC % (ttm) | -64.09 |
Dividend Yield % | -- |
Altman Z-Score | 5.68 |
LIM:MRNA Number of Guru Trades
LIM:MRNA Volume of Guru Trades
Gurus Latest Trades with LIM:MRNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LIM:MRNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data